Financial Ratios Hubei Huitian New Materials Co., Ltd.
Equities
300041
CNE100000JX8
Specialty Chemicals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.36 CNY | +0.53% |
|
+0.98% | +23.48% |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.18 | 3.6 | 3.6 | 3.24 | 1.52 | |||||
Return on Total Capital | 7.37 | 5.4 | 5.33 | 4.54 | 2.08 | |||||
Return On Equity % | 12.15 | 10.82 | 11.77 | 10.62 | 3.59 | |||||
Return on Common Equity | 12.06 | 10.97 | 11.85 | 10.67 | 3.59 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 29.99 | 22.38 | 23.39 | 22.79 | 18.2 | |||||
SG&A Margin | 12.98 | 9.4 | 10 | 9.85 | 9.5 | |||||
EBITDA Margin % | 14.55 | 9.84 | 10.2 | 10.52 | 7.67 | |||||
EBITA Margin % | 11.76 | 7.71 | 8.19 | 8.26 | 4.16 | |||||
EBIT Margin % | 11.55 | 7.53 | 8.04 | 8.11 | 3.9 | |||||
Income From Continuing Operations Margin % | 10.18 | 7.61 | 7.82 | 7.64 | 2.6 | |||||
Net Income Margin % | 10.08 | 7.7 | 7.85 | 7.66 | 2.55 | |||||
Net Avail. For Common Margin % | 10.08 | 7.7 | 7.85 | 7.66 | 2.55 | |||||
Normalized Net Income Margin | 6.73 | 4.5 | 5.22 | 4.83 | 1.96 | |||||
Levered Free Cash Flow Margin | -1.01 | -6.46 | 2.29 | -3.44 | 1.93 | |||||
Unlevered Free Cash Flow Margin | -0.66 | -6.09 | 2.67 | -2.85 | 2.9 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.72 | 0.77 | 0.72 | 0.64 | 0.62 | |||||
Fixed Assets Turnover | 2.91 | 3.22 | 3.05 | 2.57 | 2.31 | |||||
Receivables Turnover (Average Receivables) | 1.98 | 2.01 | 2.24 | 2.28 | 2.25 | |||||
Inventory Turnover (Average Inventory) | 5.16 | 5.99 | 5.66 | 5.75 | 6.17 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.69 | 1.5 | 1.77 | 1.57 | 1.47 | |||||
Quick Ratio | 1.38 | 1.22 | 1.45 | 1.32 | 1.24 | |||||
Operating Cash Flow to Current Liabilities | 0.1 | 0.06 | 0.06 | 0.3 | 0.07 | |||||
Days Sales Outstanding (Average Receivables) | 184.59 | 181.78 | 163.21 | 160 | 162.87 | |||||
Days Outstanding Inventory (Average Inventory) | 70.97 | 60.91 | 64.46 | 63.45 | 59.34 | |||||
Average Days Payable Outstanding | 159.36 | 146.69 | 145.54 | 152.97 | 135.24 | |||||
Cash Conversion Cycle (Average Days) | 96.2 | 96 | 82.13 | 70.48 | 86.97 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 17.13 | 30 | 51.68 | 58.34 | 65.31 | |||||
Total Debt / Total Capital | 14.62 | 23.08 | 34.07 | 36.85 | 39.51 | |||||
LT Debt/Equity | 3.33 | 9.57 | 36.67 | 34.4 | 33.26 | |||||
Long-Term Debt / Total Capital | 2.84 | 7.36 | 24.17 | 21.73 | 20.12 | |||||
Total Liabilities / Total Assets | 41.67 | 49.54 | 54.46 | 53.43 | 56.16 | |||||
EBIT / Interest Expense | 20.67 | 12.96 | 13.55 | 8.6 | 2.51 | |||||
EBITDA / Interest Expense | 26.05 | 16.97 | 17.28 | 11.25 | 4.94 | |||||
(EBITDA - Capex) / Interest Expense | 18.14 | -4.09 | 1.28 | 3.55 | 3.23 | |||||
Total Debt / EBITDA | 1.06 | 2.27 | 3.7 | 4.07 | 6.16 | |||||
Net Debt / EBITDA | -0.5 | -0.09 | -0.3 | 1.08 | 1.57 | |||||
Total Debt / (EBITDA - Capex) | 1.52 | -9.43 | 50.06 | 12.89 | 9.41 | |||||
Net Debt / (EBITDA - Capex) | -0.72 | 0.35 | -4.07 | 3.41 | 2.4 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 15.09 | 36.54 | 25.71 | 5.05 | 2.23 | |||||
Gross Profit, 1 Yr. Growth % | 8.84 | 1.87 | 31.38 | 2.38 | -18.38 | |||||
EBITDA, 1 Yr. Growth % | 32.23 | -8 | 29.39 | 7.71 | -25.89 | |||||
EBITA, 1 Yr. Growth % | 40.8 | -10.76 | 32.32 | 5.11 | -48.91 | |||||
EBIT, 1 Yr. Growth % | 41.93 | -10.92 | 34.23 | 5.83 | -50.87 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 39.3 | 2.09 | 29.15 | 2.58 | -65.17 | |||||
Net Income, 1 Yr. Growth % | 37.94 | 4.2 | 28.29 | 2.4 | -65.91 | |||||
Normalized Net Income, 1 Yr. Growth % | 36.16 | -8.66 | 45.75 | -2.93 | -58.39 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 41.53 | -2.78 | 27.79 | -6.63 | -62.38 | |||||
Accounts Receivable, 1 Yr. Growth % | 46.71 | 28.22 | 2.51 | 3.85 | 4.11 | |||||
Inventory, 1 Yr. Growth % | 23.81 | 35.51 | 28.21 | -14.53 | 19.24 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.75 | 38.82 | 28.03 | 22.48 | 6.33 | |||||
Total Assets, 1 Yr. Growth % | 24.42 | 31.04 | 36.84 | 3.43 | 6.44 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.75 | 12.76 | 26.36 | 4.79 | -5.46 | |||||
Common Equity, 1 Yr. Growth % | 15.88 | 13.28 | 23.65 | 5.82 | -2.72 | |||||
Cash From Operations, 1 Yr. Growth % | -40.81 | -6.3 | 8.95 | 403.24 | -72.73 | |||||
Capital Expenditures, 1 Yr. Growth % | 12.82 | 278.32 | -2.37 | -19.74 | -62.58 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -108.08 | 773.74 | -144.68 | -371.78 | -143.75 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -105.12 | 1.16K | -155.01 | -276.1 | -175.64 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 50.06 | -13.34 | 50 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 11.52 | 25.36 | 31.01 | 14.92 | 3.63 | |||||
Gross Profit, 2 Yr. CAGR % | 21.9 | 5.3 | 15.69 | 15.98 | -8.59 | |||||
EBITDA, 2 Yr. CAGR % | 36.05 | 10.48 | 9.49 | 18.42 | -10.38 | |||||
EBITA, 2 Yr. CAGR % | 49.18 | 12.27 | 9.15 | 18.39 | -26.43 | |||||
EBIT, 2 Yr. CAGR % | 50.88 | 12.44 | 9.35 | 19.22 | -27.89 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 36.23 | 19.25 | 14.83 | 15.11 | -40.22 | |||||
Net Income, 2 Yr. CAGR % | 35.55 | 19.89 | 15.62 | 14.63 | -40.91 | |||||
Normalized Net Income, 2 Yr. CAGR % | 45.99 | 11.52 | 15.38 | 18.97 | -36.45 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 39.36 | 17.3 | 11.46 | 9.38 | -40.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | 30.74 | 37.15 | 14.65 | 3.18 | 3.98 | |||||
Inventory, 2 Yr. CAGR % | 15.98 | 29.53 | 31.81 | 4.68 | 0.95 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.6 | 21.73 | 33.32 | 25.23 | 14.12 | |||||
Total Assets, 2 Yr. CAGR % | 17.77 | 27.68 | 33.91 | 18.97 | 4.92 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.66 | 15.23 | 19.37 | 15.07 | -0.47 | |||||
Common Equity, 2 Yr. CAGR % | 5 | 14.57 | 18.35 | 14.39 | 1.46 | |||||
Cash From Operations, 2 Yr. CAGR % | 60.5 | -25.53 | 1.04 | 134.16 | 17.15 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.63 | 106.6 | 92.18 | -11.48 | -45.2 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -51.36 | -15.97 | 97.59 | -16.09 | 24.89 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -59.45 | -19.62 | 163.38 | -21.37 | 35.39 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | -25.49 | - | 14.03 | 14.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.61 | 19.31 | 25.48 | 21.71 | 10.52 | |||||
Gross Profit, 3 Yr. CAGR % | 16.38 | 14.82 | 13.36 | 11.07 | 3.16 | |||||
EBITDA, 3 Yr. CAGR % | 22.5 | 19.55 | 16.72 | 9.12 | 1.5 | |||||
EBITA, 3 Yr. CAGR % | 30.61 | 25.83 | 18.94 | 8.07 | -10.3 | |||||
EBIT, 3 Yr. CAGR % | 31.52 | 26.58 | 19.28 | 8.18 | -11.28 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 25.72 | 23.74 | 22.46 | 10.59 | -22.72 | |||||
Net Income, 3 Yr. CAGR % | 25.51 | 24.17 | 22.63 | 11.04 | -23.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | 29.2 | 24.86 | 21.93 | 8.94 | -16.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 26.58 | 23.6 | 20.7 | 5.17 | -23.36 | |||||
Accounts Receivable, 3 Yr. CAGR % | 27.13 | 29.9 | 24.47 | 10.93 | 3.49 | |||||
Inventory, 3 Yr. CAGR % | 9.97 | 22.16 | 29.09 | 14.09 | 9.33 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.19 | 20.03 | 23.8 | 29.6 | 18.58 | |||||
Total Assets, 3 Yr. CAGR % | 14.19 | 22.04 | 30.67 | 22.86 | 14.63 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.13 | 7.97 | 18.83 | 14.3 | 7.78 | |||||
Common Equity, 3 Yr. CAGR % | 1.18 | 7.69 | 17.52 | 14.02 | 8.37 | |||||
Cash From Operations, 3 Yr. CAGR % | 21.9 | 34.14 | -15.46 | 72.55 | 14.35 | |||||
Capital Expenditures, 3 Yr. CAGR % | 36.24 | 57.51 | 60.92 | 43.65 | -33.57 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -13.18 | 27.37 | -31.92 | 83.23 | -26.07 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -24.64 | 27.51 | -29.17 | 98.3 | -13.67 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -13.13 | -5.9 | - | 24.95 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 17.28 | 21.16 | 19.64 | 17.53 | 16.23 | |||||
Gross Profit, 5 Yr. CAGR % | 15.27 | 12.07 | 16.1 | 15.28 | 4.01 | |||||
EBITDA, 5 Yr. CAGR % | 23.63 | 13.04 | 17.2 | 19.26 | 5.14 | |||||
EBITA, 5 Yr. CAGR % | 30.42 | 17.11 | 21.63 | 23.02 | -1.7 | |||||
EBIT, 5 Yr. CAGR % | 31.4 | 17.59 | 22.16 | 23.58 | -2.46 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 21.41 | 18.43 | 21.24 | 20.21 | -8.08 | |||||
Net Income, 5 Yr. CAGR % | 21.08 | 18.57 | 21.46 | 20.26 | -8.43 | |||||
Normalized Net Income, 5 Yr. CAGR % | 29.14 | 15.58 | 23.48 | 22.47 | -6.04 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 20.97 | 16.83 | 20.3 | 17.7 | -9.14 | |||||
Accounts Receivable, 5 Yr. CAGR % | 22.26 | 27.82 | 21.98 | 18.47 | 15.83 | |||||
Inventory, 5 Yr. CAGR % | 15.11 | 17.5 | 18.23 | 14.84 | 17 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.05 | 11.75 | 18.27 | 22.08 | 19.83 | |||||
Total Assets, 5 Yr. CAGR % | 13.53 | 19.1 | 21.7 | 20.8 | 19.69 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.73 | 7.27 | 8.06 | 10.76 | 10.7 | |||||
Common Equity, 5 Yr. CAGR % | 5.18 | 6.91 | 7.73 | 10.32 | 10.81 | |||||
Cash From Operations, 5 Yr. CAGR % | 33.05 | 2.66 | 13.08 | 67.62 | -3.67 | |||||
Capital Expenditures, 5 Yr. CAGR % | -7.98 | 62.7 | 56.34 | 25.08 | 4.59 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -30.39 | 29.29 | 20.63 | 7.79 | -22.19 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -35.77 | 27.52 | 24.31 | 5.09 | -16.1 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | -7.8 | -21.4 | -3.14 | 1.61 |
Select your edition
All financial news and data tailored to specific country editions
















